Brokerages Set OptimizeRx Co. (NASDAQ:OPRX) Price Target at $9.06
OptimizeRx Co. (NASDAQ:OPRX – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the nine brokerages that are presently covering the firm, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 1 year price target […]
OptimizeRx Co. (NASDAQ:OPRX – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the nine brokerages that are presently covering the firm, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 1 year price target […]
